Clinical Trials Sponsored by Celergan SA

Total 1901 results

Helsinn Healthcare SA

Completed

Efficacy Study of Ginger (Zingiber Officinale) Extract "Ginpax" to Manage Nausea in Cancer Patients Receiving High Emetogenic Treatments and Standard Anti-emetogenic Therapy

Cancer | Nausea | Vomiting

Italy
Debiopharm International SA

Completed

Mass Balance Recovery and Metabolic Profile of 14C Debio 1450 Following Single Oral and Intravenous Doses in Healthy Male Subjects

Healthy

United Kingdom
Cerenis Therapeutics, SA

Completed

Effect of CER-001 on Plaque Volume in Homozygous Familial Hypercholesterolemia (HoFH) Subjects (MODE)

Homozygous Familial Hypercholesterolemia

United States, Canada, Italy, Netherlands, United Kingdom
Helsinn Healthcare SA

Completed

Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients

Postoperative Nausea and Vomiting

Russian Federation, Ukraine
Biosensors Europe SA

Unknown

BioFreedom US IDE Feasibility Trial

Ischemic Heart Disease | Stable Angina | Unstable Angina | Silent Ischemia

United States
Debiopharm International SA

Completed

A Multiple Dose Study of Debio 1450 [Intravenous (IV) and Oral] in Healthy Volunteers

Bacterial Infections

United States
Cerenis Therapeutics, SA

Completed

Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial (CHI SQUARE)

Acute Coronary Syndrome

Canada, United States, France, Netherlands
Debiopharm International SA

Completed

Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma

Neoplasms | Lymphoma | Cancer | Solid Tumors

France
Bio Sidus SA

Unknown

Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and Forteo

Postmenopausal Osteoporosis With Pathological Fracture

Argentina
Quantum Genomics SA

Completed

Phase I Study in Healthy Male Subjects Comparing QGC001 to Placebo

Essential Hypertension

France
Miracor Medical SA

Completed

Safety And Feasibility Study Of Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO) In Patients With Coronary Artery Disease Undergoing Native Vessel Intervention (PICSO)

Stable Angina

Netherlands
Debiopharm International SA

Completed

Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients

Fibrosis | Inflammation | Pulmonary Fibrosis | Lung Disease | Acute Respiratory Distress Syndrome | Respiratory Distress Syndrome, Adult | Respiratory Disorders

France, Italy, Spain, Tunisia
Allergan Medical

Completed

Safety and Effectiveness of Style 410 Silicone-Filled Breast Implant Study

Breast Augmentation | Breast Reconstruction | Revision of Augmentation or Reconstruction

United States
Allergan Medical

Completed

Safety and Effectiveness of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants

Breast Augmentation | Breast Reconstruction | Revision of Augmentation or Reconstruction

United States
Allergan Medical

Completed

Safety and Effectiveness of JUVÉDERM™ Injectable Gel With Lidocaine

Nasolabial Folds

United States
Allergan Medical

Completed

European Union (EU) Post-Market Study on Easyband®

Morbid Obesity

Belgium, Netherlands, United Kingdom, Italy
Allergan Medical

Completed

The Volumizing Effect of Juvéderm VOLUMA® in the Mid-Face

Age-related Volume Deficit in the Mid-face

Belgium, Netherlands, Germany, United Kingdom
Allergan

Recruiting

18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) (ARGOS)

Ocular Hypertension | Open-angle Glaucoma

United States
Allergan

Completed

A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old

Temple Hollowing

United States, Puerto Rico
Allergan

Completed

A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Toxin-Naïve Adult Participants With Glabellar Lines

Glabellar Lines

United States, Canada
Allergan

Completed

CoolSculpting® Elite for Non-Invasive Fat Reduction

Non-invasive Fat Reduction

United States, France, Singapore, Sweden, Germany
Allergan

Completed

A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence

Platysma Prominence

United States, Belgium, Canada, Germany, United Kingdom
Allergan

Enrolling by invitation

A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)

Irritable Bowel Syndrome

United States
Allergan

Completed

Safety and Effectiveness of the XEN45 Glaucoma Treatment System in Patients With Angle Closure Glaucoma

Glaucoma | Angle-Closure

Australia, Canada, Korea, Republic of, Singapore, Taiwan, United Kingdom
Allergan

Completed

A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily (Virgo)

Presbyopia

United States
Allergan

Completed

Study of the Safety and Effectiveness of JUVÉDERM VOLUX™ XC Injectable Gel for Restoring Jawline Definition

Jawline Definition

United States
Allergan

Completed

Long Term Prospective Uncontrolled Study Of Earfold™ For The Treatment Of Prominent Ears (FOLD)

Prominent Ears

United Kingdom
Allergan

Completed

A Study to Evaluate Androderm®'s Effect on Blood Pressure in Adult Hypogonodal Male Participants

Hypogonadism

United States
Allergan

Completed

Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease

Dry Eye Disease (DED)

United States
Allergan

Completed

A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants

Hypothyroidism | Thyroid Disease | Euthyroid | Thyroid Gland | Thyroid Hormones

United States
Allergan

Completed

A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

Glaucoma | Open-Angle Ocular Hypertension

Spain, United States, Singapore, Australia, Denmark, France, Poland, Russian Federation, Thailand
Allergan

Completed

A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia (GEMINI 2)

Presbyopia

United States
Allergan

Completed

Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia (GEMINI 1)

Presbyopia

United States
Allergan

Terminated

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03

Diabetes Mellitus | Gastroparesis

United States, Canada, Australia, Russian Federation, India, Thailand, Korea, Republic of, Singapore, Mexico, Israel, Poland, Belgium, Bulgaria, Malaysia, Philippines, Ukraine, South Africa, Austria, Brazil, United Kingdom, Arge... and more
Allergan

Completed

Intradermal (ID) BOTOX in the Treatment of Facial Fine Lines

Facial Fine Lines

United States
Allergan

Terminated

Goblet Cell Degranulation Produced by Intranasal Tear Neurostimulator (ITN) in Dry Eye Disease

Dry Eye Syndromes

United States
Allergan

Completed

A Study to Evaluate the Effectiveness of Juvéderm® VOLIFT™ With Lidocaine for Lip Augmentation (LIPS)

Lip Augmentation

Portugal, United Kingdom
Allergan

Completed

Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

United States, Singapore, Italy, United Kingdom, Egypt, Korea, Republic of, Argentina, Canada, Colombia, Czechia, Germany, Malaysia, New Zealand, South Africa, Turkey
Allergan

Completed

12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine

Episodic Migraine

United States
Allergan

Completed

Eluxadoline Bile Acid Malabsorption (BAM) Study

Irritable Bowel Syndrome With Diarrhea

United States
Allergan

Completed

Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine

Migraine

United States
Allergan

Terminated

Clinical Study to Evaluate Tear Characteristics Following Acute TrueTear™ Use

Dry Eye Syndromes

United Kingdom
Allergan

Completed

A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia

Presbyopia

United States
Allergan

Completed

Safety and Efficacy of TrueTear™ for the Treatment of Meibomian Gland Disease

Dry Eye Syndromes | Meibomian Glands

United States
Allergan

Completed

Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration

Macular Degeneration

United States, Japan, United Kingdom, Italy, Taiwan, Australia, Canada, Hungary, Poland, Russian Federation, Netherlands, Brazil, Denmark, Peru, South Africa, Turkey
Allergan

Completed

A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration (CEDAR)

Macular Degeneration

Spain, United States, Korea, Republic of, Israel, Singapore, Argentina, Germany, France, Czechia, Austria, Philippines, Switzerland, Chile, Colombia, Hong Kong, Latvia, New Zealand
Allergan

Terminated

Safety and Effectiveness of NATRELLE® 410 Highly Cohesive, Anatomically Shaped, Silicone-filled X-Style and L-Style Breast Implants

Breast Augmentation | Breast Reconstruction | Breast Implant Revision

United States
Allergan

Terminated

NATRELLE® 410 X-Style and L-Style Breast Implants Continued Access Study

Breast Augmentation | Breast Reconstruction | Breast Implant Revision

United States
Allergan

Completed

A Long-Term Extension Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity

Urinary Incontinence

United States, Belgium, Czechia, Canada, France, Italy, Poland, Turkey
Allergan

Completed

Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients

Urinary Incontinence

United States, Belgium, Canada, Poland, Italy, France, Czechia, Turkey

3

Subscribe